AzTrials
AzTrials

HIV InfectionsYouthnetsNCT00255944

Effectiveness of an Online Prevention Program in Reducing the Risk of STD Infection in Young Adults

A study testing Youthnet Internet-based program in people with HIV Infections and Sexually Transmitted Diseases, run by University of Colorado, Denver at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will evaluate the effectiveness of a tailored interactive online risk reduction program versus a standard online risk reduction program in reducing the risk of Sexually Transmitted Diseases (STD) infection in young adults. Read more about this study

Who is it for?
Ages 18 to 25 yearsHealthy volunteers can take part
Conditions the study is for
HIV Infections, Sexually Transmitted Diseases
What is being tested?
Youthnet Internet-based program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2,622 participants
Where
1 siteUnited States
Study dates
Oct 2005to Dec 2008
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Has access to the internet
  • Has an e-mail address

Who cannot join

  • Colorado resident

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Internet-Based, accessible from anywhere

    Bethesda, Maryland, 20892

Other trials in United States

About this study

Official title: Internet-based Efficacy Trial of an HIV Prevention Program

This study will evaluate the effectiveness of a tailored interactive online risk reduction program versus a standard online risk reduction program in reducing the risk of Sexually Transmitted Diseases (STD) infection in young adults.

Read the detailed description

Adolescents and young adults are at the greatest risk for acquiring an STD. Approximately 3 million people between the ages of 18 and 24 become infected each year. Education about the risks and consequences of unprotected sex is a powerful tool that can be used to prevent or reduce the risk of infection. The program in this study will deliver messages to educate participants about condom use and the risk of STD infection. This study will evaluate the effectiveness of a tailored interactive online risk reduction program versus a standard online risk reduction program in reducing the risk of STD infection in young adults.

Participants in this 1-year open-label study will be recruited exclusively via the internet. Participants will be randomly assigned to receive internet-based messages from either the Youthnet program or the control program. Messages from the Youthnet program will be interactive and tailored specifically to Human Immunodeficiency Virus/Sexually Transmitted Diseases (HIV/STD) risk reduction. The control program will deliver standard STD/HIV prevention messages. Participants will be assessed at baseline and a follow-up session 4 months after enrollment. Frequency of condom use and attitudes toward condom use will be assessed using behavioral scales.

Being tested
Youthnet Internet-based program, Control Internet based program
Keywords
HIV Prevention, Internet Intervention, STDs
Medical subject headings
HIV Infections, Sexually Transmitted Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Youthnet Internet-based programBehavioural

    Messages from the Youthnet program will be interactive and tailored specifically to HIV/STD risk reduction. Participants will be exposed to five flash computer vignettes of 30 seconds each, concerning condom attitudes, norms self-efficacy, and risk awareness.

  • Control Internet based programBehavioural

    The control program will deliver standard STD/HIV prevention messages.

Study groups in NCT00255944
Study groupRoleWhat they receive
Youthnet messages on FacebookExperimentalParticipants will receive internet-based messages from the Youthnet program
Receives: Behavioral: Youthnet Internet-based program
Messages on Facebook about current eventsActive comparatorParticipants will receive internet-based messages from the control program
Receives: Behavioral: Control Internet based program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Efficacy of Internet-based Program for Increasing Condom Use With Non-main Sex Partners

    Measured: Month 2 post baseline

Secondary outcomes (1)
  1. Efficacy of Internet-based Program for Increasing Condom Use Attitudes, Norms, and Intentions With Non-main Sex Partners

    Measured: Month 2 post baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Nov 2005 (estimated)
  2. Study startOct 2005
  3. Primary completionNov 2008
  4. Study completionDec 2008

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
2,622 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00255944
Sponsor's protocol ID
02-0764b
Other IDs
R01MH063690, DAHBR 9A-ASI
Acronym
Youthnets
Status last verified
Sep 2020
First submitted
16 Nov 2005
Last updated
5 Oct 2020
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Youthnet Internet-based program in people with HIV Infections and Sexually Transmitted Diseases, run by University of Colorado, Denver at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 5 Oct 2020). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Efficacy of Internet-based Program for Increasing Condom Use With Non-main Sex Partners (time frame: Month 2 post baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Oct 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in